Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  GeneThera, Inc.    GTHR

GENETHERA, INC. (GTHR)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
06/08/2018 06/11/2018 06/12/2018 06/18/2018 06/20/2018 Date
0.0165(c) 0.0165(c) 0.0165(c) 0.017(c) 0.017(c) Last
500 1 000 500 1 000 1 000 Volume
0.00% 0.00% 0.00% +3.03% 0.00% Change
More quotes
Company
GeneThera, Inc. is a biotechnology company.The company is focused on improving food safety by applying the molecular technologies to eradicate zoonotic diseases, such as Johne's, Mad Cow, Chronic Wasting, and E.coli disease.Its product candidate include Herd Guard, a management solution, which... 
More about the company
Latest news on GENETHERA, INC.
03/28GENETHERA : Management's discussion and analysis of financial condition and resu..
AQ
2016Genethera appoints scientific advisor
GL
2016Genethera secures new laboratory facilities to expand technology platforms
GL
2015Genethera, inc. issues comments on the first international research symposium..
GL
2015MYCOBACTERIUM AVIUM PARATUBERCULOSIS : The global warming of the cattle industry
GL
2015Genethera appoints two new members on its board of directors
GL
2015GeneThera Enters Into Exclusive Collaboration Agreement with Hudson Robotics ..
GL
2008GENETHERA INC COM USD0.002 : GeneThera Announces it is Set to Begin Commercial T..
PR
2008GENETHERA INC COM USD0.002 : GeneThera Releases Results From Initial Animal Test..
PR
2008GENETHERA INC COM USD0.002 : GeneThera - CHANGING DIRECTIONS - an Update to Shar..
PR
More news
Sector news : Biotechnology & Medical Research - NEC
02:37pNovartis, MorphoSys and Galapagos Shares Rise on News of Deal
DJ
07/09LONZA : restates 2017 figures after changing accounting standard
RE
07/03Sanofi beefs up diabetes pipeline to retrieve success
RE
06/29European stocks shrug off trade worries with quarterly gain
RE
06/29GILEAD SCIENCES : Rival Novartis, Gilead CAR-T therapies win European panel reco..
RE
More sector news : Biotechnology & Medical Research - NEC
Chart GENETHERA, INC.
Duration : Period :
GeneThera, Inc. Technical Analysis Chart | GTHR | US37185E3062 | 4-Traders
Managers
NameTitle
Antonio Milici Chairman, President & Chief Executive Officer
Tannya L. Irizarry Chief Financial & Administrative Officer
Bruce Winslett Director
Sector and Competitors
1st jan.Capitalization (M$)
GENETHERA, INC.70.00%0
CELLTRION, INC.--.--%32 830
IQVIA HOLDINGS INC12.03%22 488
LONZA GROUP9.31%21 400
INCYTE CORPORATION-25.70%14 887
SEATTLE GENETICS, INC.27.16%10 750